Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 84, Topic 4
In Progress

Supportive Care and Monitoring in ICU Delirium, Agitation & Anxiety

Lesson Progress
0% Complete
Supportive Care in ICU Delirium, Agitation & Anxiety

Supportive Care and Monitoring in ICU Delirium, Agitation & Anxiety

Objective Icon A target symbol, representing a learning objective.

Objective

Recommend supportive care and monitoring to manage complications associated with delirium, agitation & anxiety in the ICU.

1. Mechanical Ventilation in Agitated Patients

Mechanical ventilation may be required when severe agitation compromises airway protection, oxygenation, or ventilator synchrony. The primary goals are to ensure patient safety and gas exchange while minimizing sedation-related harms. An analgesia-first strategy is paramount.

Key Indications for Intubation

  • Loss of Airway Reflexes: Inability to protect the airway, indicated by a diminished cough or gag reflex, increases aspiration risk.
  • Refractory Hypoxemia: Failure to maintain adequate oxygenation despite high-flow nasal cannula or noninvasive positive pressure ventilation.
  • Severe Ventilator Dyssynchrony: Patient-ventilator asynchrony that is unresponsive to sedation adjustments and compromises ventilation.

Sedation and Weaning Strategies

The goal is to use the minimum effective sedation to achieve safety and comfort, facilitating rapid liberation from the ventilator.

  • Sedation Targets: Aim for light sedation (Richmond Agitation-Sedation Scale [RASS] –2 to 0), where the patient is arousable to voice. Avoid deep sedation (RASS ≤ –4), which is linked to prolonged ventilation, increased delirium, and long-term cognitive impairment.
  • Weaning Considerations: Pair daily spontaneous breathing trials (SBTs) with sedation interruption. Before declaring an SBT failure, systematically address and treat pain and delirium. Dexmedetomidine is often preferred for agitated patients during weaning due to its minimal respiratory depression.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Dexmedetomidine for Weaning

In agitated, intubated patients, an infusion of dexmedetomidine (0.2–0.7 µg/kg/h) has been shown to shorten the time to extubation compared to haloperidol. It also reduces the need for supplemental sedatives like benzodiazepines, thereby mitigating their associated risks.

Scenario IconA clipboard with a document, indicating a clinical scenario. Clinical Scenario

A 68-year-old intubated patient with pneumonia develops agitation (RASS +2) despite scheduled haloperidol. The team decides to switch to a dexmedetomidine infusion, titrating to maintain a RASS of –2 to 0. After 12 hours, the patient is calm, arousable, and successfully passes a spontaneous breathing trial, leading to extubation.

2. Prevention of ICU-Related Complications

Sedated and immobilized ICU patients are at high risk for venous thromboembolism (VTE), stress-related mucosal bleeding, and device-associated infections. Prophylaxis using bundled, evidence-based interventions is critical to reducing morbidity.

Prophylaxis Bundles for Common ICU Complications
Complication Prophylaxis Strategy Key Agents & Considerations
Venous Thromboembolism (VTE) Pharmacologic prophylaxis is standard. Use LMWH or UFH. Switch to mechanical compression (IPCs) if active bleeding or platelets < 50,000/µL.
Stress Ulcer Bleeding Indicated for high-risk patients only. High risk: mechanical ventilation >48h or coagulopathy. Use PPIs (e.g., pantoprazole 40 mg IV daily). Avoid in low-risk patients due to pneumonia risk.
Ventilator-Associated Pneumonia (VAP) VAP Prevention Bundle Elevate head-of-bed 30-45°, perform daily sedation vacations and SBTs, use oral chlorhexidine rinses, maintain endotracheal cuff pressure.
Central Line-Associated Bloodstream Infection (CLABSI) CLABSI Prevention Bundle Maximal barrier precautions on insertion, use chlorhexidine for skin prep, perform daily line necessity review, and ensure prompt removal.
Catheter-Associated UTI (CAUTI) CAUTI Prevention Bundle Avoid unnecessary catheterization, use aseptic insertion technique, maintain a closed drainage system, and ensure prompt removal.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Nurse-Driven Protocols

Empowering nurses to initiate and adjust VTE and sedation protocols based on clear criteria has been shown to achieve over 90% compliance, significantly lowering VTE events and reducing rates of delirium and mechanical ventilation duration.

3. Environmental and Nonpharmacologic Interventions

Optimizing the ICU environment and promoting patient engagement are powerful, low-risk strategies to mitigate delirium, reduce anxiety, and support functional recovery. These interventions form the foundation of the ABCDEF bundle.

Sleep Hygiene

  • Noise and Light Control: Systematically reduce ambient noise and light, especially at night. Provide patients with earplugs and eye masks to promote restorative sleep.
  • Cluster Care: Group nursing tasks, medication administration, and lab draws to create protected blocks of time for uninterrupted sleep.

Early Mobilization and Cognitive Reorientation

  • Early Mobility: Initiate passive or active range-of-motion exercises within 48 hours of ICU admission, as soon as the patient is hemodynamically stable. Progress systematically to sitting, standing, and ambulation.
  • Cognitive Reorientation: Encourage family presence to provide familiar social interaction. Use clocks, calendars, and personal photographs to orient the patient. Nurses should frequently reorient the patient to person, place, and time.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Power of Reorientation

Implementing a standardized reorientation protocol, delivered by the nursing team every 2 hours during waking hours, has been shown to reduce the prevalence of delirium by as much as 25% in at-risk ICU patients.

4. Management of Iatrogenic Complications

Pharmacotherapies used to manage agitation and delirium carry significant risks. Vigilant monitoring and proactive management are essential to prevent harm from cardiac effects, neurologic syndromes, oversedation, and withdrawal.

Management of Common Iatrogenic Complications
Complication Key Features / Monitoring Management
QTc Prolongation Caused by antipsychotics (hERG blockade). Monitor baseline ECG; repeat 2-4h post-dose in high-risk patients. Discontinue or switch agent if QTc > 500 ms or increases by ≥ 60 ms. Correct electrolyte abnormalities (K+, Mg++).
Extrapyramidal Symptoms (EPS) Acute dystonia, parkinsonism, or akathisia (restlessness) from dopamine blockade. Treat with benztropine 1–2 mg IV or diphenhydramine 25–50 mg IV. Consider switching to a lower-potency agent.
Neuroleptic Malignant Syndrome (NMS) Rare but life-threatening. Look for fever, severe muscle rigidity, autonomic instability, and elevated CK. Immediately stop antipsychotic. Provide supportive care (cooling, hydration) and start dantrolene.
Oversedation & Withdrawal Prolonged sedation leads to weakness. Abrupt cessation of benzodiazepines or opioids causes withdrawal. Perform daily sedation interruptions. For withdrawal, implement a gradual taper (e.g., reduce infusion by 10-20% daily).
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Haloperidol Dosing

The risk of Torsades de Pointes increases markedly with cumulative haloperidol doses > 20 mg/day. When required, use low, intermittent doses (e.g., 0.5–1 mg IV every 2-4 hours) and prioritize QTc monitoring.

5. Sedation and Analgesia Protocols

A structured, protocolized approach to sedation and analgesia is proven to improve outcomes. Key principles include prioritizing pain control (analgesia-first), maintaining light sedation, and performing daily awakenings to assess neurologic function and readiness for liberation.

Daily Spontaneous Awakening & Breathing Trial (SAT/SBT) Protocol A flowchart illustrating the daily protocol for sedation interruption. It starts with a safety screen, proceeds to stopping sedation (SAT), assesses awakening, and if successful, moves to a breathing trial (SBT) to evaluate for extubation readiness. Patient on Continuous Sedation 1. Pass Daily SAT Safety Screen? Yes No (e.g., seizure, unstable) Interrupt Sedation (Perform SAT) 2. Patient Awakens & Tolerates? No (e.g., dangerous agitation) Restart Sedation at 50% of Prior Rate Yes Perform SBT 3. Pass SBT? Yes Consider Extubation No
Figure 1: Daily Spontaneous Awakening & Breathing Trial (SAT/SBT) Protocol. This nurse-driven protocol systematically reduces sedation exposure and assesses readiness for ventilator liberation, leading to shorter ventilation times and ICU stays.

6. Multidisciplinary Goals of Care Conversations

In the context of critical illness, it is vital to involve patients (when able), families, and the entire care team in ongoing discussions. These conversations help align intensive medical treatments with the patient’s values, preferences, and overall prognosis.

Ethical Considerations and Palliative Care

  • Burdens vs. Benefits: Regularly re-evaluate the goals of invasive support. Is the current treatment plan achieving the desired outcome, or is it merely prolonging suffering?
  • Palliative Care Integration: Engage palliative care specialists early, especially for patients with refractory symptoms, a high burden of therapy, or a poor prognosis. Their expertise is invaluable for managing complex symptoms and facilitating difficult conversations.

Communication Tools

Structured communication frameworks can help guide these sensitive discussions:

  • SPIKES Protocol:
    • Setting: Ensure a private, comfortable setting.
    • Perception: Ask what the family understands about the situation.
    • Invitation: Ask for permission to share information.
    • Knowledge: Give information in clear, simple terms.
    • Empathy: Acknowledge and validate emotions.
    • Summary: Summarize the plan and check for understanding.
  • Documentation: Clearly document advance directives, code status, and patient/family preferences in the medical record to ensure all team members are aware of the established goals.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Value of Rounds

Regular, structured interdisciplinary rounds that include the bedside nurse, physician, pharmacist, and respiratory therapist enhance communication, improve transparency, and foster consensus on daily goals of care, leading to more consistent and patient-centered treatment plans.

References

  1. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
  2. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
  3. Reade MC, O’Sullivan K, Bates S, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised controlled trial. Crit Care. 2009;13(3):R75.
  4. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644–2653.
  5. Girard TD, Exline MC, Carson SS, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med. 2018;379(26):2506–2516.
  6. Lewis K, Al-Abdwani S, Titi L, et al. The effect of a standardized reorientation protocol on delirium in a general intensive care unit: a before-and-after study. Crit Care Med. 2025;53(3):e711–e727.
  7. Shehabi Y, Howe BD, Bellomo R, et al. Early Sedation with Dexmedetomidine in Critically Ill Patients. N Engl J Med. 2019;380(26):2506–2517.